Decoding the Complexity of Immune-Cancer Cell Interactions: Empowering the Future of Cancer Immunotherapy.

Autor: Maffuid K; Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Publikováno v: Cancers [Cancers (Basel)] 2023 Aug 21; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 21.

Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.

Autor: Eljilany, Islam¹ (AUTHOR), Coleman, Sam² (AUTHOR), Tan, Aik Choon² (AUTHOR), McCarter, Martin D.³ (AUTHOR), Carpten, John⁴ (AUTHOR), Colman, Howard^2,5 (AUTHOR), Naqash, Abdul Rafeh⁶ (AUTHOR), Puzanov, Igor⁷ (AUTHOR), Arnold, Susanne M.⁸ (AUTHOR), Churchman, Michelle L.⁹ (AUTHOR), Spakowicz, Daniel¹⁰ (AUTHOR), Salhia, Bodour⁴ (AUTHOR), Marin, Julian¹¹ (AUTHOR), Ganesan, Shridar¹² (AUTHOR), Ratan, Aakrosh¹³ (AUTHOR), Shriver, Craig¹⁴ (AUTHOR), Hwu, Patrick¹ (AUTHOR), Dalton, William S.⁹ (AUTHOR), Weiner, George J.¹⁵ (AUTHOR), Conejo-Garcia, Jose R.¹⁶ (AUTHOR)

Publikováno v: Cells (2073-4409). Dec2024, Vol. 13 Issue 23, p1993. 16p.

Translational Approach to Predicting the Efficacy of Maraviroc-Based Regimens as HIV Preexposure Prophylaxis.

Autor: Srinivas N; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cottrell M; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Maffuid K; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Prince HA; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nelson JAE; Virology, Immunology and Microbiology Core, UNC Center for AIDS Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., White N; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Sykes C; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dellon ES; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Madanick RD; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Shaheen NJ; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kashuba ADM; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA akashuba@unc.edu.; Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2020 Jan 27; Vol. 64 (2). Date of Electronic Publication: 2020 Jan 27 (Print Publication: 2020).

Prognostic Value of Fas/Fas Ligand Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Patients with Metastatic Breast Cancer.

Autor: Papadaki, Maria A.¹ (AUTHOR) helenipapa@hotmail.com, Papadaki, Eleni¹ (AUTHOR) bio3457@edu.biology.uoc.gr, Chatziavraam, Sofia¹ (AUTHOR) daggouraki@yahoo.co.uk, Aggouraki, Despoina¹ (AUTHOR) k.michailidou@uoc.gr, Michaelidou, Kleita¹ (AUTHOR) cfotsitzoudis@pagni.gr, Fotsitzoudis, Charalampos^1,2 (AUTHOR) marvasila@uoc.gr, Vassilakopoulou, Maria¹ (AUTHOR) mavroudis@uoc.gr, Mavroudis, Dimitrios^1,2 (AUTHOR) agelaki@uoc.gr, Agelaki, Sofia^1,2 (AUTHOR)

Publikováno v: Cancers. Sep2024, Vol. 16 Issue 17, p2927. 16p.

Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis.

Autor: Cottrell ML; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Prince HMA; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill., Schauer AP; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Sykes C; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Maffuid K; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Poliseno A; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Chun TW; HIV Immunovirology Unit, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Huiting E; HIV Immunovirology Unit, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Stanczyk FZ; Keck School of Medicine, University of Southern California, Los Angeles., Peery AF; School of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill., Dellon ES; School of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill., Adams JL; Philadelphia College of Pharmacy, University of the Sciences, Pennsylvania.; Cooper University Hospital Early Intervention Program, Camden, New Jersey., Gay C; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill., Kashuba ADM; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics.; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Nov 27; Vol. 69 (12), pp. 2201-2204.